+91 8086000608 help@dermavue.com Open All Days · 7 Clinics
Home
All Conditions Acne Psoriasis Eczema Vitiligo Melasma Alopecia Dandruff Ringworm Rosacea Fungal Infection Seborrheic Dermatitis Acne Scars Hyperpigmentation Warts Contact Dermatitis Keloids Urticaria (Hives) Lichen Planus Folliculitis Skin Tags
Hair Transplant FUE Technique (SMART FUE) Hair Transplant Cost Beard & Mustache Transplant Eyebrow Transplantation Hair Loss Treatment Male Pattern Baldness Female Hair Loss GFC vs PRP Comparison PRP for Hair GFC PRP Platelet-Rich Fibrin (PRF) Mesotherapy Medical Treatments
Laser Hair Removal Botox Treatment Dermal Fillers HydraFacial & OxyGeneo Chemical & Enzyme Peels Laser Tattoo Removal Skin Whitening Treatment Glutathione IV Therapy MNRF Laser Toning Carbon Laser Peel Thread Lift Skin Booster Injections Non-Surgical Rhinoplasty Non-Surgical Jawline & Chin Fractional CO2 Lasers Surgical CO2 Ablation Surgical Tattoo Excision Mole, Wart & Skin Tag Removal Underarm Lightening Hand Rejuvenation Excessive Sweating Body Peel Hand and Foot Peel All Procedures →
Face Rhinoplasty (Nose Job) Non-Surgical Rhinoplasty Eye Bag Reduction Upper Eyelid Blepharoplasty Buccal Fat Removal Jawbone Contouring Eyebrow Lift Lip Reduction Dimple Creation Ear Reshaping Surgery Earlobe Repair Double Chin Reduction Body Liposuction Gynecomastia Arm Fat Correction Brachioplasty (Arm Lift) Fat Grafting Skin Scar Revision Mole Removal Xanthelasma Removal Lipoma Removal Cyst Excision
SuperHuman Program GLP-1 Injections Ozempic & Wegovy (Semaglutide) Mounjaro (Tirzepatide) Belly Fat Reduction Diet Plan & Nutrition Exercise & Fitness Plan GLP-1 Eligibility Explorer PCOS Risk Assessment Titration Protocol Tool BMR / TDEE Calculator GLP-1 Side Effects Toolkit
Before & After Shop
Coimbatore Thrissur Kochi Aluva Kottayam Thiruvalla Thiruvananthapuram Kollam
BOOK A SESSION
📞 +91 8086000608 ✉ help@dermavue.com
DERMAVUE THIRUVANANTHAPURAM (TRIVANDRUM) — DERMATOPHYTOSIS CLINIC

Recalcitrant Ringworm & Fungal Infection Treatment in Thiruvananthapuram — Resistant Dermatophytosis Protocols

4.7 (1309+ Reviews) T. indotineae Aware KOH + Fungal Culture IADVL Consensus Protocols

India is in the middle of an unprecedented dermatophytosis epidemic. Since 2014, a newly described species — Trichophyton indotineae — has replaced the older T. rubrum and T. mentagrophytes across most urban centres, and up to 70–80% of isolates now show reduced susceptibility to terbinafine (Rudramurthy et al., 2018; Kaul et al., 2018). At DermaVue Thiruvananthapuram (Trivandrum), MD DVL dermatologists diagnose resistant ringworm, tinea corporis, tinea cruris, onychomycosis and steroid-modified tinea using KOH microscopy, dermoscopy and fungal culture — then build an itraconazole-based, IADVL-consensus treatment plan tailored to each patient. 1309+ verified Google reviews.

WhatsApp Thiruvananthapuram
4.7★ — 1309+ Google Reviews Board-Certified MDs KOH & Dermoscopy Testing 92% Cure Rate Physician-Performed
Pattom 12 min Kowdiar 14 min Vellayambalam 16 min Nalanchira 10 min Kesavadasapuram 16 min Ulloor 15 min Technopark 18 min Kazhakkoottam 22 min Sreekaryam 20 min Medical College 8 min Peroorkada 18 min Mannanthala 25 min Kovalam 30 min Balaramapuram 25 min Pappanamcode 22 min Venganoor 25 min Kalliyoor 18 min Menamkulam 20 min Neyyattinkara 35 min Nedumangad 38 min Attingal 40 min Varkala 45 min Vakkom 35 min Kattakada 30 min Nagercoil 65 min
THE INDIAN DERMATOPHYTOSIS EPIDEMIC — QUICK ANSWER

Why Ringworm in India Is No Longer an Ordinary Skin Infection

Since 2014, India has been the epicentre of a global outbreak of recalcitrant, terbinafine-resistant dermatophytosis. A newly described species, Trichophyton indotineae, now accounts for the majority of tinea corporis, cruris and faciei isolates across urban India, and up to 70 to 80 percent of these isolates carry point mutations in the squalene epoxidase (SQLE) gene that confer resistance to terbinafine (Rudramurthy et al., Antimicrobial Agents and Chemotherapy, 2018; Kaul et al., Indian Dermatology Online Journal, 2018). Sustained 80%+ year-round humidity in coastal Kerala accelerates transmission, but the real driver of the epidemic is widespread over-the-counter use of betamethasone-based steroid-antifungal combination creams (Verma & Vasani, IJDVL, 2016), which mask inflammation, thin the epidermis and drive selection of resistant strains. DermaVue Thiruvananthapuram follows the IADVL SIG-ID ECTODERM expert consensus for the management of dermatophytosis in India — KOH and culture-confirmed diagnosis, itraconazole-first systemic therapy, and clearance confirmed at follow-up.

COMPREHENSIVE FUNGAL CARE

Types of Fungal Infections We Treat at DermaVue Thiruvananthapuram

Each fungal infection has its own causative organism, diagnostic test and evidence-based drug regimen. DermaVue dermatologists confirm the species with KOH microscopy — and, in recalcitrant cases, fungal culture — before prescribing therapy in line with the IADVL ECTODERM consensus.

Ringworm of the Body
Tinea Corporis · T. indotineae
Large, coalescing, intensely itchy annular plaques with active scaly borders. In India, now predominantly caused by T. indotineae and frequently terbinafine-resistant. First-line: oral itraconazole 200 mg/day for 6 to 8 weeks plus topical luliconazole.
Jock Itch
Tinea Cruris
Red, sharply marginated plaques in the groin folds and upper thighs, often extending to the buttocks and abdomen. Frequently recurrent in men in hot humid climates. Treated with oral itraconazole or fluconazole plus topical sertaconazole and antifungal dusting powder.
Athlete's Foot
Tinea Pedis
Interdigital scaling, maceration and fissuring, or a "moccasin" pattern of chronic hyperkeratotic scaling on the soles. Risk of bacterial superinfection and cellulitis in diabetics. Managed with topical terbinafine or luliconazole and footwear hygiene; extensive disease needs oral therapy.
Scalp Ringworm
Tinea Capitis
Scaly patches, black-dot alopecia or inflammatory kerion in children. Topical therapy alone fails — the dermatophyte lives inside the hair shaft. Standard of care is oral griseofulvin or terbinafine for 6 to 8 weeks, with ketoconazole shampoo to reduce household spread.
Nail Fungus
Onychomycosis
Thickened, discoloured, crumbling nails with subungual debris. Confirmed on KOH and culture. Evidence-based options include oral terbinafine 250 mg daily or itraconazole pulse therapy, plus topical efinaconazole 10% solution for mild distal disease.
Tinea Versicolor
Pityriasis Versicolor · Malassezia
Hypopigmented or fawn-coloured, finely scaling macules across the chest, back and shoulders, fluorescing yellow-green under Wood lamp. Cleared with short-course oral itraconazole or fluconazole, then maintained with weekly ketoconazole 2% shampoo body washes.
Candida Intertrigo
Cutaneous Candidiasis
Beefy-red, macerated plaques with satellite papulopustules in axillae, inframammary folds and groin. Often associated with diabetes or obesity. Treated with topical clotrimazole or nystatin, moisture control, and glycaemic optimisation where relevant.
Majocchi Granuloma
Deep Dermatophyte Folliculitis
Perifollicular papules and nodules on the legs in women who shave, or on the trunk in patients who have applied topical steroids to ordinary ringworm. Because the fungus sits deep around hair follicles, topical therapy fails — oral itraconazole or terbinafine for 4 to 6 weeks is mandatory.
Steroid-Modified Tinea
Tinea Incognito
Atypical, poorly marginated, often pustular ringworm in patients who have used over-the-counter steroid-antifungal combination creams. One of the most common reasons for "treatment-failing" tinea in Indian clinics. Managed with drug withdrawal, KOH reconfirmation and longer-duration itraconazole.
HOST, ENVIRONMENT & DRUG-RELATED RISK FACTORS

Why Fungal Infections Become Chronic and Recurrent

Recurrent dermatophytosis in India is rarely a single-cause problem. The current consensus (IADVL SIG-ID, 2020; Verma et al., IJDVL, 2021) identifies three overlapping drivers: environmental factors that favour fungal survival, host factors that impair clearance, and drug-related factors that promote resistance. Thiruvananthapuram's sustained year-round humidity of 80 percent and above is one ingredient — the others matter at least as much.

Environmental and behavioural risk

  • Prolonged occlusion from tight or synthetic clothing, wet footwear and unchanged undergarments
  • Sharing of towels, bedsheets, combs and garments within the household
  • Shared facilities such as gym mats, locker rooms, and community pools
  • Incomplete drying of skin folds after bathing or swimming

Host factors that impair fungal clearance

  • Uncontrolled diabetes mellitus and metabolic syndrome
  • Topical or systemic immunosuppression, including long-term corticosteroid use
  • Atopic dermatitis and impaired skin barrier function
  • Pregnancy, which limits systemic antifungal options
  • HIV or other causes of cellular immune dysfunction

Drug-related drivers of resistance

  • Over-the-counter use of betamethasone-clotrimazole and similar fixed-dose combinations
  • Incomplete or under-dosed terbinafine courses (too short, sub-therapeutic dose)
  • Pharmacy-driven self-medication without KOH or culture confirmation
  • Circulation of T. indotineae carrying SQLE gene mutations

Evidence-Based Prevention Measures

  • Thoroughly dry skin folds, web spaces and groin after bathing
  • Change out of sweat-soaked or rain-soaked clothing at the earliest opportunity
  • Launder clothing, towels and bed linen at 60°C, and sun-dry where possible
  • Rotate footwear daily and allow shoes to dry fully between wears
  • Avoid sharing personal items: towels, combs, razors, undergarments
  • Never apply a steroid, or a steroid-antifungal combination, to undiagnosed rash
  • Screen and treat symptomatic household contacts simultaneously
  • Optimise blood sugar control if diabetic — HbA1c below 7 percent
PUBLIC HEALTH ALERT

The Dangerous Truth About Steroid-Antifungal Combination Creams

India's Rs. 400 crore topical steroid market is the most important single driver of the country's resistant dermatophytosis epidemic. The IADVL has formally petitioned the Drugs Controller General of India to restrict these products.

⚠️

Steroid-Antifungal Combinations: The IADVL Position

Fixed-dose creams combining a potent topical steroid — typically betamethasone, clobetasol or mometasone — with clotrimazole or similar imidazoles are sold over the counter across India despite being scheduled as prescription-only. Published IADVL consensus statements (Verma & Vasani, IJDVL, 2016) have described them as a public health hazard.

Mechanistically, the steroid component suppresses the cutaneous immune response that would normally contain the dermatophyte. Fungus spreads deeper along hair follicles (Majocchi granuloma), the clinical picture becomes atypical (tinea incognito), and repeated sub-therapeutic drug exposure selects for resistant T. indotineae strains. Chronic use also produces irreversible epidermal atrophy, telangiectasia, striae, hypopigmentation and, in intertriginous sites, secondary bacterial infection.

Clinical recommendation: If you have applied any combination cream for more than two weeks, stop immediately and present for dermatologist assessment. At DermaVue Thiruvananthapuram, KOH microscopy is performed in-clinic, fungal culture is arranged where recalcitrance is suspected, and therapy is selected per the IADVL ECTODERM expert consensus — with no fixed-dose steroid-antifungal combinations used at any stage.

EVIDENCE-BASED PROTOCOL

Our 4-Step Fungal Infection Treatment Approach

Every patient at DermaVue Thiruvananthapuram is managed through a structured, IADVL-aligned four-step protocol. Empirical prescribing without mycological confirmation is not used at any stage.

Step 1 — Mycological Diagnosis

Clinical examination with dermoscopy (translucent scales, bent hairs, dermatophytic folliculitis), in-clinic KOH 10 to 20 percent microscopy, Wood lamp examination for tinea versicolor and erythrasma, and Sabouraud dextrose agar culture with speciation for recalcitrant or previously treated disease. Fasting glucose and HbA1c are checked in extensive or recurrent cases.

Step 2 — Evidence-Based Antifungal Therapy

Therapy is selected per the IADVL ECTODERM consensus. First-line systemic option for tinea corporis, cruris and extensive disease is oral itraconazole 200 mg daily for 6 to 8 weeks. Terbinafine 250 to 500 mg daily is considered where susceptibility is expected. Topical luliconazole, sertaconazole or amorolfine is added. No fixed-dose steroid-antifungal combinations. Pregnancy, liver disease and drug interactions are screened before starting.

Step 3 — Adherence and Safety Monitoring

Patients are reviewed at 2 and 6 weeks. Liver function tests are repeated where systemic therapy exceeds 4 weeks. Household contacts are screened and treated where symptomatic. Environmental decontamination (hot-wash laundry, shoe rotation, towel separation) is reinforced. WhatsApp follow-up is available for queries between visits.

Step 4 — Confirmed Clearance and Relapse Prevention

Mycological cure is confirmed with repeat KOH at the end of therapy — clinical clearance alone is insufficient. Maintenance antifungal shampoos or powders are prescribed where recurrence risk is high (tinea versicolor, tinea cruris, tinea pedis in diabetics). Structured advice is given on modifiable risk factors identified at the first visit.

WATCH & LEARN

Fungal Infections of Skin — Prevention & Treatment

Fungal Infections of Skin

RARE FUNGAL CONDITIONS

Piedra Fungal Infection — Causes & Treatment

Piedra Fungal Infection

PERSONALIZED ASSESSMENT

Fungal Infection Type Identifier

Answer 4 quick questions to identify your likely fungal infection type and get a recommended treatment pathway.

Where is the infection located?
What does the affected area look like?
How long have you had this infection?
What have you tried so far?
COMPARE YOUR OPTIONS

DermaVue vs. Other Fungal Treatment Options in Thiruvananthapuram

Feature DermaVue TVM General Clinic / Pharmacy
Diagnosis Method KOH Testing + Dermoscopy Visual guess only
Doctor MD DVL Board-Certified GP / Pharmacist
Treatment Plan Climate-specific protocol Generic prescription
Steroid Awareness Never uses dangerous combos Often prescribes combos
Follow-up Microscopic clearance check No follow-up testing
Cure Rate 92% with maintenance High recurrence rate
Reviews 4.7★ — 1309+ Reviews Few / Unverified
FREQUENTLY ASKED QUESTIONS

Fungal Infection Treatment FAQs — Thiruvananthapuram

Why does my ringworm keep coming back even after using antifungal cream?
Since 2014, India has faced an epidemic of recalcitrant dermatophytosis driven by a new species, Trichophyton indotineae, in which 60 to 80 percent of isolates show reduced susceptibility to terbinafine (Rudramurthy et al., Antimicrobial Agents and Chemotherapy, 2018). Standard 2 to 4 week terbinafine courses often fail. At DermaVue Thiruvananthapuram we confirm the diagnosis with KOH microscopy and, where indicated, fungal culture, then follow the IADVL expert consensus on recalcitrant tinea — typically 6 to 8 weeks or longer of oral itraconazole at 200 mg daily alongside topical luliconazole or sertaconazole.
What is Trichophyton indotineae and why does it matter in India?
Trichophyton indotineae is a genetically distinct dermatophyte first characterised in Indian patients and formally named in 2020. It produces widespread, intensely itchy ringworm on the trunk, groin and limbs, often with steroid-modified features, and frequently carries mutations in the squalene epoxidase (SQLE) gene that drive terbinafine resistance (Kano et al., 2020; Ebert et al., 2020). The US CDC has since flagged it as an emerging global threat. Management requires longer courses, dose escalation, and often a switch to itraconazole or, in selected cases, griseofulvin.
Is ringworm contagious within the household?
Yes. Dermatophytes spread through direct skin contact and through fomites such as shared towels, bedsheets, combs and clothing. The IADVL SIG-ID task force recommends simultaneous evaluation and treatment of symptomatic household contacts, plus hot-water washing of clothing and linen at 60 degrees Celsius. At DermaVue Thiruvananthapuram we routinely offer household screening appointments when one family member is diagnosed with tinea corporis or cruris.
Why does tinea versicolor keep returning on my chest and back?
Tinea versicolor is caused by commensal Malassezia yeasts that are part of the normal skin microbiome. Warmth, sweat and sebum reactivate them, so recurrence rates exceed 60 percent within 2 years without maintenance (Gupta et al., Mycoses, 2015). DermaVue dermatologists use a short course of oral itraconazole or fluconazole to clear active disease, then a maintenance regimen of ketoconazole 2% shampoo used as a body wash weekly or fortnightly to keep the yeast in check.
How long does toenail fungus (onychomycosis) treatment take?
Complete mycological cure of onychomycosis requires 6 weeks of oral therapy for fingernails and 12 weeks for toenails, but the nail plate itself takes 6 to 12 months to grow out clear. Standard options include oral terbinafine 250 mg daily or itraconazole pulse therapy, with topical efinaconazole 10% solution as an adjunct or monotherapy for mild distal disease (Gupta et al., Journal of the American Academy of Dermatology, 2020). At DermaVue Thiruvananthapuram we confirm onychomycosis with KOH and, for nail dystrophy without obvious fungal elements, culture before starting systemic therapy.
Can I swim in the sea or a pool while being treated for a fungal infection?
Swimming pools and seawater do not worsen the infection, but active tinea pedis, corporis or cruris can be shed into shared water and onto pool decks, and prolonged moisture can delay healing. International guidelines and the CDC recommend keeping the affected area covered with waterproof dressing and avoiding shared facilities such as gym showers and changing rooms until KOH-confirmed clearance. Your DermaVue dermatologist will give a specific return-to-activity date at your follow-up visit.
Why are steroid-antifungal combination creams dangerous?
Over-the-counter creams combining betamethasone or clobetasol with clotrimazole are the single biggest driver of the Indian resistant ringworm epidemic. Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) position papers have called for these products to be removed from Schedule H and restricted to prescription-only status (Verma & Vasani, IJDVL, 2016; IADVL SIG-ID consensus, 2020). They mask inflammation while allowing fungus to spread deeper, produce atypical "tinea incognito," cause skin atrophy and striae, and drive selection of resistant T. indotineae strains. At DermaVue we never prescribe these fixed-dose combinations.
Is oral antifungal treatment safe during pregnancy?
Systemic terbinafine, itraconazole and fluconazole are generally avoided during pregnancy because of limited safety data and known teratogenic risk with high-dose fluconazole. For pregnant patients, DermaVue dermatologists prioritise topical therapy using pregnancy-category B agents such as clotrimazole, miconazole or ciclopirox, along with strict moisture and clothing measures. Oral therapy is deferred until after delivery and lactation wherever possible, in line with Indian and WHO antifungal stewardship guidance.
What is the consultation fee for fungal infection treatment at DermaVue Thiruvananthapuram?
The dermatology consultation fee at DermaVue Thiruvananthapuram is ₹300. This includes a full cutaneous examination, dermoscopic assessment of affected lesions, KOH microscopy when indicated, a written diagnosis, and a stepwise treatment plan. Fungal culture, Wood lamp examination, and patch testing are offered as additional investigations where clinically relevant, with costs disclosed transparently before they are performed.
Does a fungal infection mean I have poor hygiene or uncontrolled diabetes?
No. Dermatophytosis occurs across all socioeconomic groups and hygiene standards. Published risk factors include warm humid environments, occlusive clothing and footwear, shared household items, atopic skin, and immunosuppression — but most otherwise healthy adults in South India have at least one episode in their lifetime. Poorly controlled diabetes and HIV increase the risk of severe or atypical disease, including Majocchi granuloma, so DermaVue dermatologists routinely screen for fasting glucose and HbA1c in patients with extensive, recurrent or deep fungal infection.
CLINICAL AUTHORITY

About Fungal Infection Treatment at DermaVue Thiruvananthapuram

DermaVue Clinics is a physician-owned dermatology network across Kerala and Tamil Nadu that specialises in the diagnosis and management of recalcitrant, terbinafine-resistant dermatophytosis. The Thiruvananthapuram (Trivandrum) branch, located at TC 42, Poojappura Main Road, Kesari Nagar, is led by board-certified MD DVL dermatologists who evaluate ringworm and fungal skin infection referrals from across the Thiruvananthapuram district — including Technopark, Pattom, Kowdiar, Kovalam, Neyyattinkara, Attingal, Varkala and Nedumangad — and also receive patients from the neighbouring Tamil Nadu border districts.

Clinical practice at DermaVue Thiruvananthapuram follows the Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) ECTODERM expert consensus on dermatophytosis. Every patient undergoes KOH microscopy at the first visit, with Sabouraud dextrose agar culture and Wood lamp examination arranged for recalcitrant or atypical presentations. Systemic therapy is itraconazole-first for tinea corporis and cruris in accordance with published Indian susceptibility data (Rudramurthy et al., Antimicrobial Agents and Chemotherapy, 2018). Onychomycosis is managed with oral terbinafine or itraconazole pulse therapy supplemented by topical efinaconazole where appropriate. Steroid-antifungal combination creams are never prescribed, and previously steroid-modified tinea is re-diagnosed with KOH before longer-course oral therapy.

Patients are reviewed at scheduled intervals, with liver function testing where systemic therapy exceeds four weeks, simultaneous household contact screening, and mycological clearance confirmed at the end of treatment. DermaVue holds a 4.7-star rating from 1309+ verified Google reviews at its Thiruvananthapuram location. Additional references: Kaul et al., IDOJ, 2018, Verma & Vasani, IJDVL, 2016, US CDC — Ringworm, WHO Fungal Priority Pathogens List.

Stop Cycling Through Failed Antifungals

If your ringworm keeps recurring, is spreading despite treatment, or was ever treated with an over-the-counter combination cream, it may be resistant T. indotineae. DermaVue Thiruvananthapuram's MD DVL dermatologists will confirm the species with KOH and culture, and build an IADVL-consensus treatment plan from the first consultation. 1309+ verified Google reviews.

WhatsApp Thiruvananthapuram Call +91 8330860007
Call WhatsApp
Book Your Visit

Schedule a Consultation

Board-certified dermatologists across 7 clinics in Kerala & Tamil Nadu.

🔒 Your information is private and secure

Scroll to Top

Book a Consultation